The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, ...

UK drugmaker says Emma Walmsley is underpaid compared with global competitors as it abandons diversity targets ...

One of the lowest paid CEOs in pharma—and one of the only woman leading a top-tier giant—is set to receive up to $27.2 ...

GlaxoSmithKline would consider buying Pfizer’s consumer health business – but only if the price is right, according to the company's chief executive. Emma Walmsley has also been busy shaking ...

For Big Pharma CEOs, compensation can swing drastically year to year — from base salary to bonus incentives to stock options ...

Dame Emma Walmsley prides herself on her tenacity. It is something the GSK chief says she inherited from her late father, a ...

British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale ...

UK drugmaker GSK is struggling to convince the market that it can deliver on its plans to refill its pipeline ahead of a key ...

Dame Emma Walmsley Thanks Julie. so in summary, GSK is powering forward. This comes on the back of a strong track record of operational delivery and accelerating progress in innovation and ...